Wells Fargo’s Edesa Biotech EDSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-17
Closed -$71 7044
2024
Q1
$71 Buy
17
+1
+6% +$5 ﹤0.01% 6739
2023
Q4
$73 Buy
16
+1
+7% +$4 ﹤0.01% 6846
2023
Q3
$68 Sell
15
-2
-12% -$12 ﹤0.01% 6850
2023
Q2
$95 Buy
17
+1
+6% +$7 ﹤0.01% 6879
2023
Q1
$100 Buy
16
+5
+45% +$52 ﹤0.01% 6939
2022
Q4
$166 Hold
11
﹤0.01% 6673
2022
Q3
$0 Buy
11
+1
+10% +$12 ﹤0.01% 6799
2022
Q2
$0 Buy
10
+2
+25% +$29 ﹤0.01% 6944
2022
Q1
$0 Buy
8
+1
+14% +$28 ﹤0.01% 7211
2021
Q4
$0 Hold
7
﹤0.01% 7331
2021
Q3
$0 Hold
7
﹤0.01% 7059
2021
Q2
$0 Hold
7
﹤0.01% 6991
2021
Q1
$0 Buy
7
+4
+133% +$161 ﹤0.01% 6968
2020
Q4
$0 Hold
3
﹤0.01% 6582
2020
Q3
$0 Buy
3
+1
+50% +$48 ﹤0.01% 6430
2020
Q2
$0 Hold
2
﹤0.01% 6383
2020
Q1
$0 Buy
+2
New +$41 ﹤0.01% 6316
2019
Q4
Hold
0
6418
2019
Q3
Hold
0
6438
2019
Q2
Hold
0
6396
2019
Q1
Hold
0
6131
2018
Q4
Hold
0
6438
2018
Q3
Hold
0
6431
2018
Q2
Hold
0
6372
2016
Q2
Sell
-1
Closed -$2K 6142
2016
Q1
$2K Hold
1
﹤0.01% 6025
2015
Q4
$3K Buy
+1
New +$2.32K ﹤0.01% 5957

Other funds holding EDSA

Wells Fargo's EDSA Position: Q2 2024 in Review

Wells Fargo sold out of Edesa Biotech (EDSA) in Q2 2024, closing a stake of 17 shares — an estimated $71 sold.

Wells Fargo first reported a position in EDSA in Q4 2015 and held it in 19 quarters. The position peaked at $3K in Q4 2015. 17 funds tracked by Wall St. Rank hold EDSA as of Q2 2024.

  • Wells Fargo reported no remaining Edesa Biotech position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 17 Edesa Biotech shares in Q2 2024, an estimated $71.
  • Wells Fargo first reported a position in Edesa Biotech in Q4 2015 and held it in 19 quarters.
  • Wells Fargo's Edesa Biotech position peaked at $3K in Q4 2015.
  • 17 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.